Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...
Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...
Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...
Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...
Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...
Singapore: Merck Millipore, the Life Science division of Merck, has appointed Dr Udit Batra as its new President and CEO...
Singapore: US Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality s...
Singapore: Adagene, China based antibody discovery and development company, has raised USD28 million Series B financing ...
‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, ...
Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: A research team led by scientists from National University of Singapore (NUS) has identified several potent i...
Singapore: China biotech firm, Innovent Biologics, has raised $100 million in Series C financing led by Legend Capital, ...
Singapore: Scientific consensus in the Network Verification Challenge, conducted in Spain from 15-18 June 2015, has exhi...
Dr Alex Matter, CEO, Experimental Therapeutics Center, A*Star, Singapore, is among the pioneers of the world's first tar...
